A leading cause of cancer deaths worldwide, colon cancer is famously resistant to treatment. There are many reasons for this, but one has to do with a group of persisting cancer cells in the colon that cause relapses. Conventional therapies against them are mostly ineffective. EPFL scientists have now identified a biological mechanism that can be exploited to counteract colon cancer relapses. The approach activates a protein that is lost in the persisting cancer cells. The researchers were able to reactivate it using vitamin A, thus eliminating the cancer cells and preventing metastasis.
The study is published in Cancer Cell, and introduces a new way to treat colon cancer.
When a colon-cancer patient receives treatment, e.g. chemotherapy, most of the cancer cells die off. But the genetic mutations that caused the cancer in the first place can survive in a specific group of cells of the colon. These are actually stem cells, meaning that they are premature cells waiting to grow into full-blown, normal cells of the colon. After cancer treatment ends, the surviving stem cells, still containing the cancerous mutations, can reappear and cause a relapse.
The lab of Joerg Huelsken at EPFL studied how differentiated colon cells come from stem cells in the gut. Using an array of different techniques, the team looked at cells, mouse models and samples from human patients.
Proteins and signaling pathways
The study focused on a protein called HOXA5, which belongs to a family of proteins that regulate the development of the fetus. These proteins are made during early development and work together to make sure that every tissue is correctly identified and that the fetus’s body and limbs are patterned properly. In the adult body, proteins like HOXA5 regulate the body’s stem cells to maintain both the identity and function of different tissues. Huelsken’s team found that in the gut, HOXA5 plays a major role in restricting the number of stem cells, as well as the cells that make them.
Like all proteins, HOXA5 originates from a specific gene. The study showed that the cancerous stem cells of the colon use a biological mechanism that blocks it. This mechanism is called a “signaling pathway” because it involves a domino of molecules, each activating the next one down the line. The purpose of a signaling pathway is to transmit biological information from one part of the cell to another, e.g. from the outer membrane all the way to the nucleus. By blocking the HOXA5 gene, the cancerous stem cells of the colon can grow uncontrollably and spread, causing relapses and metastasis.
Retinoids: a way to fight back
The researchers looked for ways to reverse the blocking of HOXA5. The answer came from vitamin A. This small chemical structure is called a retinoid, and it has been known to induce differentiation of stem cells in the skin. The EPFL scientists found that retinoids can re-activate HOXA5. In mice that had colon cancer, the treatment with retinoids blocked tumor progression and normalized the tissue. By turning the gene for HOXA5 back on, this treatment eliminated cancer stem cells and prevented metastasis in the live animals. The researchers got similar results with samples from actual patients.
The new study suggests that patients that may profit from this well-tolerated treatment can be identified based on their expression pattern for the HOXA5 gene. Retinoid differentiation therapy could be significantly effective against colon cancer, not only for treatment of existing disease but also as a preventive measure in high-risk patients.
Read more: Treating colon cancer with vitamin A
The Latest on: Treating colon cancer with vitamin A
via Google News
The Latest on: Treating colon cancer with vitamin A
- Exercise linked to decreased colon cancer risk on April 17, 2019 at 4:00 am
Male colon cancer survivors over 40 years old whose last radiation therapy, chemotherapy, or surgical treatment was less than one month ago, were selected. They then completed an acute or chronic high ... […]
- Novel screening system revealed that intracellular cholesterol trafficking can be a good target for colon cancer prevention on April 17, 2019 at 2:22 am
8 compounds were identified as candidate chemopreventive drugs for colorectal cancer. One of those, itraconazole, is a clinically used anti-fungal drug and was examined in the Min mouse model of ... […]
- Some patients with imminently fatal cancer still receive treatment on April 15, 2019 at 2:14 pm
MN), examined treatment patterns for 100,848 adult patients in the National Cancer Data Base. All were newly-diagnosed with metastatic lung, colorectal, breast, or pancreatic cancer and died within ... […]
- Colon Cancer Changes Its Spots to Dodge Latest Immunotherapies on April 15, 2019 at 6:53 am
Scientists at The Institute of Cancer Research ... in the U.K. have found that colorectal cancer (CRC) tumors can switch off expression of a cell surface molecule that is a key target of immunotherapy ... […]
- Colorectal cancer a silent killer with no early warning symptoms on April 12, 2019 at 2:36 am
A biopsy which involves the removal of a small amount of tissue for examination under a microscope can make a definite diagnosis of colorectal cancer. Treatment for colorectal cancer depends on ... […]
- High Dose Vitamin D Beneficial For Colon Cancer on April 10, 2019 at 11:51 am
High dose vitamin D supplements have been found to help extend ... and easily accessible agent as potential treatment for colorectal cancer that could have large and wide reaching global impact ... […]
- High-Dose Vitamin D Beneficial for Colon Cancer Patients on April 10, 2019 at 6:50 am
“To our knowledge, this study is the first completed randomized clinical trial of vitamin D supplementation for treatment of advanced or metastatic colorectal cancer,” said Kimmie Ng, MD, MPH, ... […]
- Blood test flags colon cancer warning signs on April 10, 2019 at 5:14 am
PHOENIX (3TV/CBS 5) --Few medical tests are more dreaded than a colonoscopy, but making sure your colon is healthy is important. That is why Sonora Quest labs has developed a blood test to look for ... […]
- Vitamin D may slow progression of metastatic colorectal cancer on April 9, 2019 at 4:32 pm
Vitamin D, which is necessary for bone health ... and easily accessible agent as a potential new treatment for metastatic colorectal cancer. This could therefore potentially have a large and ... […]
- High-dose vitamin D shows benefit in patients with advanced colorectal cancer on April 9, 2019 at 8:20 am
"To our knowledge, this study is the first completed randomized clinical trial of vitamin D supplementation for treatment of advanced or metastatic colorectal cancer," Ng said. In the high-dose group, ... […]
via Bing News